journal
MENU ▼
Read by QxMD icon Read
search

Journal of ECT

journal
https://www.readbyqxmd.com/read/28198719/rivaroxaban-for-treatment-of-pulmonary-embolism-while-receiving-electroconvulsive-therapy
#1
Emily Shao, Rachael Moore, John Linnane
No abstract text is available yet for this article.
February 15, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28198718/switching-from-age-based-stimulus-dosing-to-dose-titration-protocols-in-electroconvulsive-therapy-empirical-evidence-for-better-patient-outcomes-with-lower-peak-and-cumulative-energy-doses
#2
Alex O'Neill-Kerr, Anhar Yassin, Stephen Rogers, Janie Cornish
OBJECTIVE: The aim of this study was to test the proposition that adoption of a dose titration protocol may be associated with better patient outcomes, at lower treatment dose, and with comparable cumulative dose to that in patients treated using an age-based stimulus dosing protocol. METHODS: This was an analysis of data assembled from archived records and based on cohorts of patients treated respectively on an age-based stimulus dosing protocol and on a dose titration protocol in the National Health Service in England...
February 15, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28178037/benefits-of-dexmedetomidine-in-management-of-post-ect-agitation
#3
Puneet Narang, Francesca Ianovich, Simrat Kaur Sarai, Steven Lippmann
Electroconvulsive therapy (ECT) is an intervention for patients with a variety of psychiatric conditions. Occasionally, people exhibit dangerous degrees of agitation after this treatment, and some do not respond well to conventional pharmacotherapies. Dexmedetomidine is a central α-2 agonist that can induce significantly calmative effects in persons with post-ECT agitation. The indication for it is in calming individuals with acute and/or recurrent posttreatment agitation. Dexmedetomidine is safe and effective when infused just before, or postictally, at ECT sessions...
February 8, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28169947/cognitive-performance-under-electroconvulsive-therapy-ect-in-ect-naive-treatment-resistant-patients-with-major-depressive-disorder
#4
Christoph Ziegelmayer, Göran Hajak, Anne Bauer, Marion Held, Rainer Rupprecht, Wolfgang Trapp
OBJECTIVES: Although electroconvulsive therapy (ECT) is considered a safe and highly effective treatment option for major depressive disorder, there are still some reservations with regard to possible adverse cognitive adverse effects. This is the case despite a large body of evidence showing that these deficits are transient and that there even seems to be a long-term improvement of cognitive functioning level. However, most data concerning cognitive adverse effects stem from studies using mixed samples of treatment-resistant and non-treatment-resistant as well as ECT-naive and non-ECT-naive subjects...
February 7, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28121663/spontaneous-seizure-from-remifentanil-induction-during-electroconvulsive-therapy
#5
Charles H Kellner, Mustafa Cicek, Kate G Farber, Wojciech Reiss, Christopher Cowart
No abstract text is available yet for this article.
January 24, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28072661/serum-oxytocin-concentration-in-patients-receiving-electroconvulsive-therapy-an-exploratory-study-and-review-of-literature
#6
Chinmay Barhale, M S V K Raju, Alka V Pawar, Krishna Kadam, Avinash De Sousa, Chittaranjan Andrade
BACKGROUND: Neuroendocrine biomarkers have long been studied in the context of electroconvulsive therapy (ECT). We prospectively assessed serum oxytocin change and moderators thereof in an exploratory study of patients receiving ECT. METHODS: Serum oxytocin concentrations were assessed immediately before and 1 to 3 minutes after the first ECT in 33 patients with schizophrenia (n = 14), other nonaffective psychosis (n = 6), mania (n = 10), and depression (n = 3) who received 6 to 7 bitemporal, brief-pulse ECTs...
January 9, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28072660/two-versus-one-high-frequency-repetitive-transcranial-magnetic-stimulation-session-per-day-for-treatment-resistant-depression-a-randomized-sham-controlled-trial
#7
Christos Theleritis, Pavlos Sakkas, Thomas Paparrigopoulos, Silia Vitoratou, Chara Tzavara, Stefania Bonaccorso, Antonios Politis, Constantin R Soldatos, Costantin Psarros
OBJECTIVES: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS) has proven antidepressant effects, but the optimal frequency of sessions remains unclear. METHODS: We conducted a 3-week, sham-controlled trial to assess the antidepressant efficacy of 1 active HF-rTMS session per day (A1 group) compared with 2 per day (A2 group) and equivalent sham sessions (once a day, S1 group; twice a day, S2 group) in patients with treatment-resistant major depression with a subsequent 2-week follow-up period...
January 9, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28072659/effects-of-transcranial-magnetic-stimulation-on-the-cognitive-control-of-emotion-potential-antidepressant-mechanisms
#8
Crystal Lantrip, Faith M Gunning, Laura Flashman, Robert M Roth, Paul E Holtzheimer
Depression negatively impacts quality of life and is associated with high mortality rates. Recent research has demonstrated that improvement in depression symptoms with transcranial magnetic stimulation (TMS) to the dorsolateral prefrontal cortex (DLPFC) may involve changes in the cognitive control network, a regulatory system modulating the function of cognitive and emotional systems, composed of the DLPFC, dorsal anterior cingulate, and posterior parietal cortices. Transcranial magnetic stimulation to the DLPFC node of the cognitive control network may have antidepressant efficacy via direct effects on cognitive control processes involved in emotion regulation...
January 9, 2017: Journal of ECT
https://www.readbyqxmd.com/read/28009627/ect-related-anxiety-a-systematic-review
#9
Jasmien Obbels, Esmée Verwijk, Filip Bouckaert, Pascal Sienaert
BACKGROUND: A significant proportion of electroconvulsive therapy (ECT)-treated patients experience anxiety anticipating the treatment, often to such an extent that they refuse or discontinue a much-needed treatment. Despite its great impact on treatment adherence, anxiety in patients receiving ECT is underexposed in the scientific literature. OBJECTIVES: We aimed to review the prevalence and specific subjects of ECT-related anxiety and therapeutic interventions to reduce it...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009626/a-successful-course-of-electroconvulsive-therapy-in-a-patient-with-epilepsy-and-a-posterior-fossa-titanium-plate
#10
Rachel B Katz, Mesut Toprak, Robert Ostroff
No abstract text is available yet for this article.
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009624/time-trends-and-variations-in-electroconvulsive-treatment-in-denmark-2008-to-2014-a-nationwide-register-based-study
#11
Eva Hundrup, Merete Osler, Martin Balslev Jørgensen
OBJECTIVE: The aim of this study was to determine status and variations in the practice of electroconvulsive treatment (ECT) in Denmark in patient characteristics, indications, treatment patterns, and hospital region. METHOD: All 140,627 ECTs registered in the Danish National Patient Registry between 2008 and 2014 were retrieved together with information on patient characteristics. Annual treated person rates were calculated for sex, age, admission diagnosis, and region...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009623/electroconvulsive-therapy-ect-and-race-a-report-of-ect-use-and-sociodemographic-trends-in-texas
#12
Julie Williams, Lawrence Chiu, Robin Livingston
OBJECTIVES: Minimal research on race and other sociodemographic disparities in patients receiving electroconvulsive therapy (ECT) exists. One previously noted national trend reveals whites receiving ECT disproportionately more than other races. The aim of this study is to determine whether a county ECT program demonstrates similar disparities observed at the state and national levels. METHODS: This study examined 21 years of ECT data, between 1993 and 2014, provided by the Texas Department of State Health Services, focusing on race, sex, age, and payer source and 2...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009621/a-meta-review-of-the-safety-of-electroconvulsive-therapy-in-pregnancy
#13
Preeti Sinha, Parth Goyal, Chittaranjan Andrade
BACKGROUND: Four systematic reviews have examined the safety of electroconvulsive therapy (ECT) in pregnancy. These have varied widely in methods, findings, and conclusions. METHODS: We compared these reviews with regard to search strategy, study selection criteria, total number of studies identified, total number of patients included, findings related to safety and adverse events, and interpretation of results. RESULTS: The number of studies (number of cases) included in the reviews ranged from 16 (n = 300) to 67 (n = 169) with only one review stating reasons for exclusion of nonselected studies...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009620/the-treatment-of-disruptive-vocalization-in-dementia-behavioral-and-psychological-symptoms-of-dementia-with-electroconvulsive-therapy-a-case-series
#14
Timothy Edwin Lau, Prakash Kishor Babani, Lisa Anne McMurray
OBJECTIVE: There is emerging evidence that electroconvulsive therapy (ECT) can help with the behavioral and psychological symptoms of dementia. One of the most distressing behavioral symptoms of dementia is disruptive vocalization. Previous small case series have suggested that antidepressants and ECT can be beneficial for this distressing condition. The aim of this study was to describe the successful use of ECT in treating 5 patients with disruptive vocalization. METHODS: A retrospective chart review of 5 patients with dementia of mixed etiologies was conducted comparing pretreatment and posttreatment scores on the Cohen-Mansfield Agitation Inventory...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28009618/electroconvulsive-therapy-considerations-for-transgendered-patients
#15
Billy K Tran, Stephen E O'Donnell, Agnes Balla, David C Adams, Lydia S Grondin, Mitchell H Tsai
As the transgender patient population continues to grow, health care providers will need to become aware of elements unique to the transgender community in order to provide the highest quality of care. Neuromuscular blockade with succinylcholine is routinely administered to patients undergoing electroconvulsive therapy (ECT). Decreased amounts or activity of pseudocholinesterase in serum can lead to prolonged duration of muscle paralysis. Causes of reduced action by pseudocholinesterase include genetically abnormal enzymes, reduced hepatic production, pregnancy, and various drug interactions...
December 21, 2016: Journal of ECT
https://www.readbyqxmd.com/read/27930429/subjective-memory-immediately-following-electroconvulsive-therapy
#16
Ole Brus, Pia Nordanskog, Ullvi Båve, Yang Cao, Åsa Hammar, Mikael Landén, Johan Lundberg, Axel Nordenskjöld
OBJECTIVES: The aims of the present study were to describe the short-term rate of subjective memory worsening (SMW) and identify factors of importance for SMW in a large clinical sample treated for depression with electroconvulsive therapy (ECT). METHODS: This register-based study included 1212 patients from the Swedish National Quality Register for ECT. Subjective memory worsening was defined as a 2-point worsening on the memory item of the Comprehensive Psychopathological Rating Scale from before to within 1 week after treatment...
December 7, 2016: Journal of ECT
https://www.readbyqxmd.com/read/27930427/a-further-decrease-in-the-rates-of-administration-of-electroconvulsive-therapy-in-england
#17
Nicky Buley, Emma Copland, Sophie Hodge, Robert Chaplin
OBJECTIVES: Electroconvulsive therapy (ECT) is an effective treatment of major depression, and there have been consistent improvements in the administration of ECT in the past decade. However, studies have reported a steady decline in the rates of use of ECT in the United Kingdom and Ireland. Despite this, there has been no consistent record of how much ECT is being given or to whom it is given, for more than 20 years. The purpose of this study is to estimate the change in frequency of ECT use, the length of courses, patient demographics, and clinical outcomes between 2006 and 2 periods of 2012/2013 and 2014/2015...
December 7, 2016: Journal of ECT
https://www.readbyqxmd.com/read/27922459/electroconvulsive-therapy-practice-in-new-zealand
#18
Mark Wilkinson Fisher, John Morrison, Paul Anthony Jones
OBJECTIVES: The aim of this study was to describe the contemporary practice of electroconvulsive therapy (ECT) in New Zealand. METHODS: A 53-item questionnaire was sent to all services providing ECT as of December 2015. RESULTS: Electroconvulsive therapy was provided by 16 services covering 15 district health boards funded by the New Zealand government. No private facilities provided ECT. All services providing ECT responded to an online survey questionnaire...
December 2, 2016: Journal of ECT
https://www.readbyqxmd.com/read/28181928/reply-to-dr-martin-s-letter-regarding-differences-in-cognitive-outcomes-after-ect-depending-on-bdnf-and-comt-polymorphisms
#19
Daniel M Bennett, Jennifer S Perrin, Gordon Fernie
No abstract text is available yet for this article.
March 2017: Journal of ECT
https://www.readbyqxmd.com/read/28072663/commentary-on-bennett-and-colleagues-differences-in-cognitive-outcomes-after-electroconvulsive-therapy-depending-on-bdnf-and-comt-polymorphisms
#20
journal
journal
33016
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"